624734-26-5

Basic information

• Product Name: tert-butyl 3-(trifluoroMethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine-6-carboxylate
• Synonyms: tert-butyl 3-(trifluoroMethyl)-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate;tert-butyl 3-(trifluoroMethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine-6-carboxylate
• CAS NO: 624734-26-5
• Molecular Formula: C14H17F3N2O2
• Molecular Weight: 302.2921896
• Mol File: 624734-26-5.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 342.4±42.0 °C at 760 mmHg
• Flash Point: 160.9±27.9 °C
• Appearance: /
• Density: 1.3±0.1 g/cm³
• PKA: 2.89±0.20(Predicted)
• CAS DataBase Reference: tert-butyl 3-(trifluoroMethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine-6-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 3-(trifluoroMethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine-6-carboxylate(624734-26-5)
• EPA Substance Registry System: tert-butyl 3-(trifluoroMethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine-6-carboxylate(624734-26-5)

Safety Data

• Hazardous Substances Data: 624734-26-5(Hazardous Substances Data)

Usage

General Description

Tert-butyl 3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine-6-carboxylate is a chemical compound with a molecular formula C17H20F3NO2. It is a derivative of tetrahydro-1,6-naphthyridine, which is a heterocyclic compound containing a ring of five carbon atoms and one nitrogen atom. The compound contains a tert-butyl group and a trifluoromethyl group, which are both commonly used in pharmaceuticals and agrochemicals. It may have potential applications in the development of new drugs or crop protection products due to its unique structure and properties.

Upstream product

• 624734-25-4 3-(trifluoromethyl)-5,8-dihydro-1,6-naphthyridin-7(6H)-one 
• 24424-99-5 di-tert-butyl dicarbonate 
• 33252-63-0 2-hydroxy-5-(trifluoromethyl)pyridine 
• 624734-24-3 tert-butyl 7-oxo-3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine-8-carboxylate 
• 624734-23-2 tert-butyl methyl [3-cyano-5-(trifluoromethyl)pyridin-2-yl]malonate 
• 624734-22-1 2-chloro-5-(trifluoromethyl)pyridine-3-carbonitrile 
• 76041-73-1 3-bromo-5-(trifluoromethyl)pyridin-2-ol 
• 129904-48-9 2-hydroxy-5-(trifluoromethyl)nicotinaldehyde 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 631-61-8 ammonium acetate 
• 741736-95-8 3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine, hydrochloride salt 

Downstream Products

• 741736-95-8 3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine, hydrochloride salt 
• 624734-27-6 3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine 

Relevant articles and documents

CHEMOKING RECEPTOR ANTAGONISTS

Disclosed herein are chemokine receptor antagonists of formula (I) wherein G1, X1, X2, and X3 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.

Spiroalkene carboxamide derivatives and their use as chemokine receptor modulators

The present invention is directed to compounds of Formula (I) below, which are antagonists to the chemoattractant cytokine receptor 2 (CCR2), and/or 5 (CCR5), pharmaceutical compositions, and methods for use thereof.

Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity

The present invention is directed to compounds of the formula I: Wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X, n and the broken lines are as defined herein which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.